View in EDS HTML Full Text PDF Full Text

Simvastatin is effective in killing the radioresistant breast carcinoma cells.

Saved in:
Bibliographic Details
Title: Simvastatin is effective in killing the radioresistant breast carcinoma cells.
Authors: Aschenbrenner B; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Moscow, Russia., Negro G; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Moscow, Russia., Savic D; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Moscow, Russia., Sorokin M; EORTC PathoBiology Group Moscow, Russia.; Institute of Personalized Medicine, Sechenov First Moscow State Medical University, Moscow, Russia.; Omicsway Corp., Walnut, USA.; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia., Buzdin A; EORTC PathoBiology Group Moscow, Russia.; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Oncobox ltd., Moscow, Russia.; World-Class Research Center 'Digital Biodesign and Personalized Healthcare', Sechenov First Moscow State Medical University, Moscow, Russia., Ganswindt U; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria., Cemazar M; EORTC PathoBiology Group Moscow, Russia.; Institute of Oncology Ljubljana, Department of Experimental Oncology, Ljubljana, Slovenia., Sersa G; Institute of Oncology Ljubljana, Department of Experimental Oncology, Ljubljana, Slovenia., Skvortsov S; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Skvortsova I; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Moscow, Russia.
Source: Radiology and oncology [Radiol Oncol] 2021 May 04; Vol. 55 (3), pp. 305-316. Date of Electronic Publication: 2021 May 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Sciendo Country of Publication: Poland NLM ID: 9317213 Publication Model: Electronic Cited Medium: Internet ISSN: 1581-3207 (Electronic) Linking ISSN: 13182099 NLM ISO Abbreviation: Radiol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33939900
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Simvastatin is effective in killing the radioresistant breast carcinoma cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aschenbrenner+B%22">Aschenbrenner B</searchLink>; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Negro+G%22">Negro G</searchLink>; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Savic+D%22">Savic D</searchLink>; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Sorokin+M%22">Sorokin M</searchLink>; EORTC PathoBiology Group Moscow, Russia.; Institute of Personalized Medicine, Sechenov First Moscow State Medical University, Moscow, Russia.; Omicsway Corp., Walnut, USA.; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Buzdin+A%22">Buzdin A</searchLink>; EORTC PathoBiology Group Moscow, Russia.; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Oncobox ltd., Moscow, Russia.; World-Class Research Center 'Digital Biodesign and Personalized Healthcare', Sechenov First Moscow State Medical University, Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Ganswindt+U%22">Ganswindt U</searchLink>; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Cemazar+M%22">Cemazar M</searchLink>; EORTC PathoBiology Group Moscow, Russia.; Institute of Oncology Ljubljana, Department of Experimental Oncology, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Sersa+G%22">Sersa G</searchLink>; Institute of Oncology Ljubljana, Department of Experimental Oncology, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Skvortsov+S%22">Skvortsov S</searchLink>; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Skvortsova+I%22">Skvortsova I</searchLink>; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Moscow, Russia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229317213%22">Radiology and oncology</searchLink> [Radiol Oncol] 2021 May 04; Vol. 55 (3), pp. 305-316. <i>Date of Electronic Publication: </i>2021 May 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sciendo%22">Sciendo </searchLink><i>Country of Publication: </i>Poland <i>NLM ID: </i>9317213 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1581-3207 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213182099%22">13182099 </searchLink><i>NLM ISO Abbreviation: </i>Radiol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33939900
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2478/raon-2021-0020
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 305
    Titles:
      – TitleFull: Simvastatin is effective in killing the radioresistant breast carcinoma cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aschenbrenner B
      – PersonEntity:
          Name:
            NameFull: Negro G
      – PersonEntity:
          Name:
            NameFull: Savic D
      – PersonEntity:
          Name:
            NameFull: Sorokin M
      – PersonEntity:
          Name:
            NameFull: Buzdin A
      – PersonEntity:
          Name:
            NameFull: Ganswindt U
      – PersonEntity:
          Name:
            NameFull: Cemazar M
      – PersonEntity:
          Name:
            NameFull: Sersa G
      – PersonEntity:
          Name:
            NameFull: Skvortsov S
      – PersonEntity:
          Name:
            NameFull: Skvortsova I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 05
              Text: 2021 May 04
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1581-3207
          Numbering:
            – Type: volume
              Value: 55
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Radiology and oncology
              Type: main
ResultId 1